Comment on

• Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men.

  Catalona WJ, Richie JP, Ahmann FR, Hudson MA, Scardino PT, Flanigan RC, DeKernion JB, Ratliff TL, Kavoussi LR, Dalkin BL, Waters WB, MacFarlane MT, Southwick PC. Catalona WJ, et al. J Urol. 1994 May;151(5):1283-90. doi: 10.1016/s0022-5347(17)35233-3. J Urol. 1994. PMID: 7512659 Clinical Trial.
• Prostate specific antigen cannot distinguish stage T1a (A1) prostate cancer from benign prostatic hyperplasia.

  Monda JM, Barry MJ, Oesterling JE. Monda JM, et al. J Urol. 1994 May;151(5):1291-5. doi: 10.1016/s0022-5347(17)35234-5. J Urol. 1994. PMID: 7512660
• Clinical experience of the detection of prostate cancer in patients with benign prostate hyperplasia treated with finasteride. The Finasteride Study Group.

  Stoner E, Round E, Ferguson D, Gormley GJ. Stoner E, et al. J Urol. 1994 May;151(5):1296-300. doi: 10.1016/s0022-5347(17)35235-7. J Urol. 1994. PMID: 7512661 Clinical Trial.
• Some small prostate cancers are nondiploid by nuclear image analysis: correlation of deoxyribonucleic acid ploidy status and pathological features.

  Greene DR, Rogers E, Wessels EC, Wheeler TM, Taylor SR, Santucci RA, Thompson TC, Scardino PT. Greene DR, et al. J Urol. 1994 May;151(5):1301-7. doi: 10.1016/s0022-5347(17)35236-9. J Urol. 1994. PMID: 8158775